Právní předpis byl sestaven k datu 23.11.2024.
Zobrazené znění právního předpisu je účinné od 27.07.2013.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2014
195/2013 Sb.
195
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 3. xxxxxxxx 2013
x xxxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2014
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx souvisejících xxxxxx, ve xxxxx xxxxxxxxxx předpisů, stanoví xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx pro xxx 2014:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx anatoxinum xxx.
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum xxxxx 1
Virus xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx typus 3
Xxxxxxxxxx Hib: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (acelulárni xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx B, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xxxxxxxxxxx anatoxinum
Tetani anatoxinum
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (inaktivovaný)
typus 1 (Xxxxxxx)
xxxxx 2 (XXX-1)
xxxxx 3 (Xxxxxxx)
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X
Xxxxxxxxxxx xxxxxxxxxx xxxx b xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx
1x) očkovací xxxxx proti záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (DTaP):
Diphtheriae xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx influenzae x (XXxXXxx):
| &xxxx;
Xxxxxxxxxxx anatoxinum
|
min. 30 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxx xxxxxxxxxx
|
&xxxx;
xxx. 40 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxx (XX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx (69xX)
|
&xxxx;
8 mikrogramů
|
|
Haemophilus xxxxxxxxxx X
|
&xxxx;
10 xxxxxxxxxx
|
| &xxxx;
xxx xxxxxxxxx xxxxxxxx
|
&xxxx;
20-40 xxxxxxxxxx
|
1x) xxxxxxxx látka proti xxxxxxx x xxxxxx - divakcína:
Anatoxinum xxxxxxxxxxx xxxxxxxxxxx ... xxx. 30 xxxxxxxxxxxxx jednotek
Anatoxinum xxxxxx xxxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae typ x:
1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx anatoxinum ... xxx. 40 mezinárodních xxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xx 15 xxx xxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X ... 10 mikrogramů
1h) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx 16 xxx a xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx
1xx) očkovací xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx kulturu50
Parotitidis xxxxx xxxxxxxxxx (XXX 4385) min. 103,7 xxxxxxxx xxxxx pro xxxxxxxx kulturu50
Rubeolae xxxxx xxxxxxxxxx (Wistar XX 27/3) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx kulturu50
1i) očkovací xxxxx xxxxx dětské xxxxxxxx xxxxx v xxxxxxxxxxxx xxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum typus 2 (MEF-1) ... 8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis inactivatum xxxxx 3 (Xxxxxxx) ... 32 antigenních X jednotek*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx pomocí vhodné xxxxxxxxxxxxx xxxxxx.
1x) xxxxxxxx xxxxx xxxxx nákazám xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x polysacharidové xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11X, 12X, 14, 15B, 17F, 18X, 19A, 19X, 20, 22F, 23X, 33X ... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X
Xxxxxxxxxxxxx polysaccharidum sérotypus 6X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14
Xxxxxxxxxxxxx polysaccharidum sérotypus 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
|
Diphtheriae xxxxxxxxxx
|
&xxxx;
xx xxxx než 2 xxxxxxxxxxx jednotky
|
|
Tetani xxxxxxxxxx
|
&xxxx;
xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxxxxxx
|
&xxxx;
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxx filamentosum
|
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
2,5 xxxxxxxxxx
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
| &xxxx;
xxxxx 1 (xxxx Mahoney)
|
40 X xxxxxxxx xxxxxxxx
|
| &xxxx;
xxxxx 2 (xxxx XXX-1)
|
&xxxx;
8 X jednotek xxxxxxxx
|
| &xxxx;
xxxxx 3 (kmen Xxxxxxx)
|
&xxxx;
32 X xxxxxxxx xxxxxxxx
|
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
|
Difterický toxoid
|
více xxxx rovno 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
|
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
xxxx nebo xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Lf)
|
Pertusové xxxxxxxx:
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
2,5 mikrogramu
|
|
Filamentózní xxxxxxxxxxxx
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxx typu 2+3
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
3 mikrogramy
|
|
Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)
|
&xxxx;
40 xxxxxxxxxxx X xxxxxxxx
|
| &xxxx;
Xxxxx poliomyelitis xxxx 2 (inaktivovaný)
|
8 xxxxxxxxxxx X jednotek
|
|
Virus poliomyelitis xxxx 3 (xxxxxxxxxxxx)
|
&xxxx;
32 xxxxxxxxxxx X xxxxxxxx
|
1x) xxxxxxxx látka xxxxx xxxxxxxxxxx:
Xxxxxxxx Calmette Guérin (xxxxxxxxxx) 100&xxxx;000 - 300&xxxx;000 X.X.*
(xxxx Copenhagen 1331)
*X.X. = živé xxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx hepatitidě X pro xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid A (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx
2x) očkovací látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx dospělé:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B ... 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx XX/XX 38&xxxx;1503-3X xxxx xxxx rovno 2,5 xxxxxxxxxxxxx jednotek x 1 xxxxx (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X ve formuli xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx mimořádná xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X virus xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxx:
Xxxxx xxxxxxxxx X inactivatum
Ministr:
doc. XXXx. Xxxxx, XXx., x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 195/2013 Xx. nabyl xxxxxxxxx xxxx 27.7.2013.
Xx xxx xxxxxxxx právní xxxxxxx xxxxx měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx předpisů x odkazech xxxx xxxxxxxxxxxxx, pokud xx xxxx xxxxxx derogační xxxxx shora uvedeného xxxxxxxx xxxxxxxx.